TP53 and cancer: A significant association has been reported between tumour stage and cancer-related genetic alterations, such as nucleotide changes in TP53, KRAS, APC and allelic imbalances, in the blood of patients affected by breast, ovarian, pancreatic, colorectal cancer and oral carcinoma as well as HCC [52,53,54].